CAR—T细胞免疫疗法的研究进展(综述)

CAR—T细胞免疫疗法的研究进展(4)

http://www.100md.com 2018年10月25日《中西医结合心血管病电子杂志》 2018年第30期

[7]JENSEN M C，POPPLEWELL L，COOPER L J，et al.Antitransgene rejection responses contribute to attenuated persistence of adoptively transferred CD20/CD19-specific chimeric antigen receptor redirected T cells in humans [J].Biology of blood and marrow transplantation ：journal of the American Society for Blood and Marrow Transplantation，2010，16(9)：1245-56.

[8]RIBERA J M.Efficacy and safety of bispecific T-cell engager blinatumomab and the potential to improve leukemia-free survival in B-cell acute lymphoblastic leukemia [J].Expert review of hematology ......

上一页第 1 2 3 4 页

百拇医药网 http://www.100md.com/html/paper/2095-6681/2018/30/05-3.htm

您现在查看是摘要页，全文长 3298 字符。